Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Vytora Health vs RxSpan MD

Two GLP-1 desks, one scoreboard. We put Vytora Health and RxSpan MD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 16 · Grade B+

Vytora Health

Visit Vytora Health Full brief →
vs
No. 85 · Grade C

RxSpan MD

Visit RxSpan MD Full brief →

The verdict

Vytora Health takes this head-to-head.

Vytora Health scores 87 to 72 on our six-factor Brief Score — A rare accredited provider that pairs brand-name access with fair mid-market compounded pricing across all 50 states.

That doesn't make RxSpan MD a bad call — it's best for readers who want to check who is prescribing and who is compounding before they buy, and who will change the pre-selected plan back to monthly unless they actually mean to pay a year up front. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
85
66
Supply Reliability
87
82
Transparency
88
56
Access Breadth
90
88
Clinical Oversight
88
78
Track Record
82
62
Vytora HealthBrief Score 87 · 72RxSpan MD

Price, coverage & the tracker

Vytora HealthRxSpan MD
Brief Score87/100 (B+)72/100 (C)
Semaglutide$150/mo$249/mo month-to-month, compounded — the funnel pre-selects a 3-month prepay at $657 up front, and its cheapest rung is $2,327 for a year in one charge
Tirzepatide$200/mo$329/mo month-to-month, compounded — 3 months bills $927 up front, 12 months $3,228
CoverageAll 50 statesAll 50 states claimed — asynchronous review is not available in all of them
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

Vytora Health: $150 sema / $200 tirz nationwide; LegitScript-certified with brand-name access.

RxSpan MD: First reading of the live catalog, 8 August 2026, replacing a dataset line that had never been checked against it. Month-to-month is $249 semaglutide and $329 tirzepatide; the ladder runs down to $194 and $269 a month, but only by paying $2,327 or $3,228 in a single charge. The cheapest GLP-1 figures RxSpan publishes anywhere — $179 and $199, in its own product API — are on no storefront page and buy nothing.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.